Guilarte Mar, Santos Javier, de Torres Inés, Alonso Carmen, Vicario María, Ramos Laura, Martínez Cristina, Casellas Francesc, Saperas Esteban, Malagelada Juan Ramón
Department of Medicine, Hospital Universitari General Vall d'Hebron, 08035 Barcelona, Spain.
Gut. 2007 Feb;56(2):203-9. doi: 10.1136/gut.2006.100594. Epub 2006 Sep 27.
BACKGROUND: Increased numbers of mast cells and mast cell activation in distal gut segments are associated with symptom onset and severity in irritable bowel syndrome (IBS). Although upper gut symptoms are common, mast cells have not been thoroughly evaluated in proximal gut in IBS patients. METHODS: Jejunal biopsies obtained by Watson's capsule, aspiration of intestinal fluid and one blood sample were obtained in 20 diarrhoea-predominant patients with IBS (D-IBS) and 14 healthy volunteers (H). Psychological stress (Holmes-Rahe Scale) and depression (Beck's Depression Inventory) were evaluated at baseline and food and respiratory allergy excluded. Biopsies were processed for H&E staining and microscopic inflammation assessed by counting intraepithelial lymphocytes. Mast cells in lamina propria were counted by immunohistochemistry with CD117 (c-kit). Tryptase concentration was measured in intestinal fluid and serum. RESULTS: D-IBS patients showed higher psychological stress than healthy volunteers (D-IBS: 203 (SD 114) v H: 112 (SD 99); p = 0.019). Immunohistochemical staining of jejunal mucosa revealed mild increase in intraepithelial CD3+ cells in D-IBS patients (D-IBS: 15.3 (SD 5.5; 95% CI 12.7 to 17.9) v H: 10.3 (SD 3.9; 95% CI 8.0 to 12.5); p = 0.006). Moreover, D-IBS patients showed marked increase in mast cells numbers (D-IBS: 34 (SD 9.3); H: 15.3 (SD 4.4) mast cells/hpf; p<0.001) and higher tryptase concentration in jejunal fluid (D-IBS: 0.45 (SD 0.38); H: 0.09 (SD 0.10) microg/l; p = 0.005). Upper gut symptoms were not associated with gender, mast cell counts, jejunal tryptase or basal stress. CONCLUSION: This jejunal mucosal inflammatory profile may help identify diarrhoea-predominant IBS, a stress-related disorder.
背景:远端肠道段肥大细胞数量增加和肥大细胞活化与肠易激综合征(IBS)的症状发作及严重程度相关。尽管上消化道症状很常见,但IBS患者近端肠道中的肥大细胞尚未得到充分评估。 方法:对20例腹泻型肠易激综合征(D-IBS)患者和14名健康志愿者(H)进行了经沃森胶囊获取空肠活检、抽取肠液及采集一份血样。在基线时评估心理应激(霍尔姆斯-拉赫量表)和抑郁(贝克抑郁量表),并排除食物和呼吸道过敏。对活检组织进行苏木精-伊红染色,通过计数上皮内淋巴细胞评估微观炎症。用CD117(c-kit)免疫组化法计数固有层中的肥大细胞。测量肠液和血清中的类胰蛋白酶浓度。 结果:D-IBS患者的心理应激高于健康志愿者(D-IBS:203(标准差114)对H:112(标准差99);p = 0.019)。空肠黏膜免疫组化染色显示D-IBS患者上皮内CD3 +细胞轻度增加(D-IBS:15.3(标准差5.5;95%置信区间12.7至17.9)对H:10.3(标准差3.9;95%置信区间8.0至12.5);p = 0.006)。此外,D-IBS患者的肥大细胞数量显著增加(D-IBS:34(标准差9.3);H:15.3(标准差4.4)个肥大细胞/高倍视野;p<0.001),空肠液中的类胰蛋白酶浓度更高(D-IBS:0.45(标准差0.38);H:0.09(标准差0.10)μg/l;p = 0.005)。上消化道症状与性别、肥大细胞计数、空肠类胰蛋白酶或基础应激无关。 结论:这种空肠黏膜炎症特征可能有助于识别腹泻型肠易激综合征,一种与应激相关的疾病。
Am J Gastroenterol. 2011-3-22
Scand J Gastroenterol. 2014-1
Trop Parasitol. 2024
Nat Microbiol. 2023-10
Arch Pathol Lab Med. 2006-3
Neurogastroenterol Motil. 2006-1
Gastroenterol Clin North Am. 2005-6
Gastroenterol Clin North Am. 2005-6
Annu Rev Immunol. 2005